glp-1 receptor agonist news agonists show promise in treating substance use disorders GLP-1 Receptor Agonist Market Growth

As an antioxidant, it reduces oxidative stress, brightens the skin complexion with its detoxification and reduces skin inflammation

Nn s dng kem dng m ph hp vi loi da ca bn dng m da mi ngy

FDA staff's own briefing document, posted publicly ahead of the meeting as part of the docket, proposes that TB-500 (free base) and TB-500 acetate not be added to the list, citing incomplete physicochemical characterization, a lack of evidence of effectiveness for wound healing (including an in-vitro fibroblast study in which TB-500 reportedly did not induce wound healing), and insufficient nonclinical and clinical safety data

First the good news: GLP-1s can help offset the very real and very common issue of postmenopausal weight gain, says Tan

However, like any injectable treatment, it may carry some risks such as allergic reactions, injection site discomfort, or mild side effects like nausea